Cargando…
A New Trade Framework for Global Healthcare R&D
Current business models for drug development are inefficient and ineffective - drugs are not reaching all who need them. Hubbard and Love contend that it is time to explore some alternatives
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC340954/ https://www.ncbi.nlm.nih.gov/pubmed/14966544 http://dx.doi.org/10.1371/journal.pbio.0020052 |
| Sumario: | Current business models for drug development are inefficient and ineffective - drugs are not reaching all who need them. Hubbard and Love contend that it is time to explore some alternatives |
|---|